Segui questo link per vedere altri tipi di pubblicazioni sul tema: Vaccines.

Articoli di riviste sul tema "Vaccines"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Vaccines".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

Ricke, Darrell O. "Epilepsy adverse events post vaccination." Exploration of Neuroscience 3, no. 6 (2024): 508–19. http://dx.doi.org/10.37349/en.2024.00062.

Testo completo
Abstract (sommario):
Aim: Seizure and epilepsy adverse events (AEs) can occur following vaccination. For epilepsy AEs, they are generally expected to only occur at background population frequencies without associations with immunizations. The Vaccine AEs Reporting System (VAERS) collects a subset of AEs experienced by vaccinees, including multiple epilepsy related AEs. This study examines the possibility of immunization associated epilepsy AEs in VAERS occurring above background rates. Methods: Herein, VAERS is retrospectively examined for epilepsy and seizure AEs following immunizations (AEFIs). Reported AEFIs ar
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Okanlawon, A. A., S. A. Ameen, R. A. Kadir, et al. "In vitro assessment of the potency of some Newcastle disease vaccine brands in Ibadan, Nigeria." African Journal of Clinical and Experimental Microbiology 21, no. 4 (2020): 328–32. http://dx.doi.org/10.4314/ajcem.v21i4.9.

Testo completo
Abstract (sommario):
Background: Newcastle disease (ND) is a very common and economically important disease of poultry. There is no drug for treatment of the disease during an outbreak in poultry flocks, and prevention by vaccination is one of the recommended control measures. However, post vaccination outbreaks have been observed on many occasions in chicken flocks and one of the causes has been attributed to possible failure of vaccine to confer immunity. This study was designed to evaluate the potency of ND vaccines available in Ibadan, Nigeria.
 Methodology: Haemagglutination (HA) technique and elution ph
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Luxi, Nicoletta, Francesco Ciccimarra, Chiara Bellitto, et al. "Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study." Vaccines 12, no. 9 (2024): 1059. http://dx.doi.org/10.3390/vaccines12091059.

Testo completo
Abstract (sommario):
Background: Conventional vaccines rarely cause severe allergic reactions. However, the rapid development and approval of COVID-19 vaccines left limited initial data on their adverse reactions, particularly in individuals with a history of allergy. The aim of this study was to assess and compare the safety profile of different doses and brands of COVID-19 vaccines in subjects with a history of allergy vs. those without a history of allergy. Methods: From February 2021 to February 2023, a web-based prospective study gathered vaccinee-reported outcomes using electronic questionnaires across eleve
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Ricke, Darrell O. "Etiology model for many vaccination adverse reactions, including SARS-CoV-2 spike vaccines." AIMS Allergy and Immunology 6, no. 4 (2022): 200–215. http://dx.doi.org/10.3934/allergy.2022015.

Testo completo
Abstract (sommario):
<abstract><sec> <title>Objective</title> <p>Vaccinated individuals (vaccinees) experience no adverse events, mild adverse events, multiple adverse events, or serious adverse events post vaccination. Many of these vaccine adverse events occur with different vaccines with different occurrence frequencies. Many of these adverse events are generally considered as associated with immune responses to the active vaccine components (antigens) and/or to possibly one or more of the vaccine excipients. Most of these vaccine adverse events are self-limiting and resolve within
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Broderick, Michael P., Sandra Romero-Steiner, Gowrisankar Rajam, et al. "Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone." Clinical and Vaccine Immunology 23, no. 8 (2016): 672–80. http://dx.doi.org/10.1128/cvi.00267-16.

Testo completo
Abstract (sommario):
ABSTRACTImmunological responses to vaccination can differ depending on whether the vaccine is given alone or with other vaccines. This study was a retrospective evaluation of the immunogenicity of a tetravalent meningococcal conjugate vaccine for serogroups A, C, W, and Y (MenACWY) administered alone (n= 41) or concomitantly with other vaccines (n= 279) to U.S. military personnel (mean age, 21.6 years) entering the military between 2006 and 2008. Concomitant vaccines included tetanus/diphtheria (Td), inactivated polio vaccine (IPV), hepatitis vaccines, and various influenza vaccines, among oth
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Trombetta, Claudia Maria, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani, and Serena Marchi. "Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines." Vaccines 10, no. 5 (2022): 714. http://dx.doi.org/10.3390/vaccines10050714.

Testo completo
Abstract (sommario):
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups. To date, three types of influenza vaccines have been licensed: inactivated, live-attenuated, and recombinant haemagglutinin vaccines. Effectiveness studies allow an assessment of the positive effects of influenza vaccines in the field. The effectiveness of current influenza is suboptimal, being estimated as 40% to 60% when the vaccines strains are antigenically well-matched with the circulating vir
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Yagovkin, E. A., G. G. Onishchenko, A. Yu Popova, et al. "Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection." Epidemiology and Vaccine Prevention 15, no. 4 (2016): 74–82. http://dx.doi.org/10.31631/2073-3046-2016-15-4-74-82.

Testo completo
Abstract (sommario):
This review summarizes the material on the development of vaccines against (nonpolio) enterovirus infection in Russia and abroad. Described the developed vaccine types, their characteristics and the results of clinical and epidemiological trials, created in China inactivated vaccines. I’is considered the possibility of creating a mucosal vaccines and vaccinal prevention strategies.
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Cojocaru, Ina, Oxana Grosu, Lilia Rotaru, Galina Corcea, Stela Odobescu, and Ion Moldovanu. "Neurological complications post – COVID-19 vaccination." Bulletin of the Academy of Sciences of Moldova. Medical Sciences 80, no. 3 (2025): 54–61. https://doi.org/10.52692/1857-0011.2024.3-80.09.

Testo completo
Abstract (sommario):
Following vaccination of the population against Covid-19 infection, a multitude of neurological complications have been reported, from the most frequently encountered to the rarest. In our article we present a narrative analysis of two databases: PubMed and Google Scholar for all types of published studies (case reports, case series, cross-sectional study with a meta-analytic literature review, systematic review, meta-analysis, retrospective study, cohort study). Headache is one of the most publicized, early onset complications, it can be migraine type - 51.1% and tension type - 27.4%, most fr
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Le, Ting, Chao Sun, Jitao Chang, Guijie Zhang, and Xin Yin. "mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases." Viruses 14, no. 2 (2022): 401. http://dx.doi.org/10.3390/v14020401.

Testo completo
Abstract (sommario):
In the prevention and treatment of infectious diseases, mRNA vaccines hold great promise because of their low risk of insertional mutagenesis, high potency, accelerated development cycles, and potential for low-cost manufacture. In past years, several mRNA vaccines have entered clinical trials and have shown promise for offering solutions to combat emerging and re-emerging infectious diseases such as rabies, Zika, and influenza. Recently, the successful application of mRNA vaccines against COVID-19 has further validated the platform and opened the floodgates to mRNA vaccine’s potential in infe
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Cheng, Liqin, Yan Wang, and Juan Du. "Human Papillomavirus Vaccines: An Updated Review." Vaccines 8, no. 3 (2020): 391. http://dx.doi.org/10.3390/vaccines8030391.

Testo completo
Abstract (sommario):
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated information about current HPV vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination and current clinical trials are also discussed. Currently, more efforts should be put into increasing the vaccine’s coverage, especially in low- and middle-income countries. Provision of education on HPV and vaccination is one
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Choi, Wongyeong, and Eunha Shim. "Vaccine Effects on Susceptibility and Symptomatology Can Change the Optimal Allocation of COVID-19 Vaccines: South Korea as an Example." Journal of Clinical Medicine 10, no. 13 (2021): 2813. http://dx.doi.org/10.3390/jcm10132813.

Testo completo
Abstract (sommario):
The approved coronavirus disease (COVID-19) vaccines reduce the risk of disease by 70–95%; however, their efficacy in preventing COVID-19 is unclear. Moreover, the limited vaccine supply raises questions on how they can be used effectively. To examine the optimal allocation of COVID-19 vaccines in South Korea, we constructed an age-structured mathematical model, calibrated using country-specific demographic and epidemiological data. The optimal control problem was formulated with the aim of finding time-dependent age-specific optimal vaccination strategies to minimize costs related to COVID-19
Gli stili APA, Harvard, Vancouver, ISO e altri
12

Neri, Margherita, Simon Brassel, and Lotte Steuten. "OP256 Recognising The Broader Value Of Vaccines In Health Technology Assessment: Worth A Shot?" International Journal of Technology Assessment in Health Care 37, S1 (2021): 9–10. http://dx.doi.org/10.1017/s0266462321000878.

Testo completo
Abstract (sommario):
IntroductionThe COVID-19 pandemic shows that the impact of effective vaccines extends well beyond vaccinated individuals and healthcare systems. Yet, these externalities are not typically considered in health technology assessments (HTA) which may underestimate vaccines’ broader value. We explored to what extent future vaccines relevant to England might exhibit such broader value.MethodsWe compared the ten value elements of an existing vaccine evaluation framework to the value elements considered in England according to the Joint Committee on Vaccine and Immunisation (JCVI) and the National In
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Malik, Sumira, Shristi Kishore, Sagnik Nag, et al. "Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges." Vaccines 11, no. 2 (2023): 268. http://dx.doi.org/10.3390/vaccines11020268.

Testo completo
Abstract (sommario):
The global outgoing outbreaks of Ebola virus disease (EVD) in different regions of Sudan, Uganda, and Western Africa have brought into focus the inadequacies and restrictions of pre-designed vaccines for use in the battle against EVD, which has affirmed the urgent need for the development of a systematic protocol to produce Ebola vaccines prior to an outbreak. There are several vaccines available being developed by preclinical trials and human-based clinical trials. The group of vaccines includes virus-like particle-based vaccines, DNA-based vaccines, whole virus recombinant vaccines, incompet
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Turabian, Jose Luis. "Relative and Temporal Efficacy of the First and Second Covid 19 Booster Vaccine (3rd And 4th Dose) to Prevent Symptomatic Infection from December 2021 to October 2023 in a General Medicine Office in Toledo (Spain)." Journal of Health Care and Research 5, no. 1 (2024): 39–48. http://dx.doi.org/10.36502/2024/hcr.6234.

Testo completo
Abstract (sommario):
Background: The effectiveness of COVID-19 vaccines in preventing serious infection and death is established, but their protection against infection is less certain. Additionally, their effectiveness diminishes over time. Furthermore, the evolution of the effectiveness of different booster doses of the vaccine against COVID-19, to prevent symptomatic infection in real life during the pandemic and the subsequent endemic, is not clearly documented. Objective: To compare the effectiveness of the 3rd and 4th vaccine boosters against COVID-19 in preventing symptomatic COVID-19 infection during both
Gli stili APA, Harvard, Vancouver, ISO e altri
15

Ricke, Darrell O. "Vaccines Associated Cardiac Adverse Events, Including SARS-Cov-2 Myocarditis, Elevated Histamine Etiology Hypothesis." Journal of Virology and Viral Diseases 2, no. 2 (2022): 1–11. http://dx.doi.org/10.54289/jvvd2200108.

Testo completo
Abstract (sommario):
Background: Rare cardiac adverse events are reported post vaccinations. For the SARS-CoV-2 mRNA Spike vaccines, higher numbers of these cardiac adverse events are being reported with myocarditis disproportionately occurring in younger males. The etiology of these cardiac adverse events associated with vaccines including SARS-CoV-2 is unknown. The etiology of the higher frequency of these cardiac adverse events temporally associated with SARS-CoV-2 mRNA Spike vaccines is also unknown. Aim: Data mine vaccine associated cardiac adverse events to gain insights into COVID-19 mRNA associated myocard
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Thiele, Sonja, Aljona Borschewski, Judit Küchler, Marc Bieberbach, Sebastian Voigt, and Bernhard Ehlers. "Molecular Analysis of Varicella Vaccines and Varicella-Zoster Virus from Vaccine-Related Skin Lesions." Clinical and Vaccine Immunology 18, no. 7 (2011): 1058–66. http://dx.doi.org/10.1128/cvi.05021-11.

Testo completo
Abstract (sommario):
ABSTRACTTo prevent complications that might follow an infection with varicella-zoster virus (VZV), the live attenuated Oka strain (V-Oka) is administered to children in many developed countries. Three vaccine brands (Varivax from Sanofi Pasteur MSD; Varilrix and Priorix-Tetra, both from Glaxo-Smith-Kline) are licensed in Germany and have been associated with both different degrees of vaccine effectiveness and adverse effects. To identify genetic variants in the vaccines that might contribute to rash-associated syndromes, single nucleotide polymorphism (SNP) profiles of variants from the three
Gli stili APA, Harvard, Vancouver, ISO e altri
17

Kashitu-Mujinga, Gracia, Anguy Makaka-Mutondo, Meris Matondo-Kuamfumu, et al. "Assessment of Oral Poliovirus Vaccine Viability and Titer at Delivery Points in Kinshasa, the Democratic Republic of the Congo: Implications for Cold Chain Management." Vaccines 13, no. 7 (2025): 680. https://doi.org/10.3390/vaccines13070680.

Testo completo
Abstract (sommario):
Background: Poliomyelitis is a vaccine-preventable disease, with oral poliomyelitis vaccines (OPVs) and injectable poliomyelitis vaccines. In the Democratic Republic of the Congo (DRC), circulating vaccine-derived polioviruses (VDPVs) persist due to intrinsic and extrinsic factors, including the quality of the cold chain, which may make the vaccines less effective. This study’s objective was to evaluate the cold chain’s quality of OPVs and its effect on the vaccine’s viability and potency at different levels in health systems in Kinshasa. Methods: A cross-sectional study was conducted in Kinsh
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Ritesh Abuj, Narendra Sonawane, Shreyash Chougule, and S.G. Joshi. "Secure and Transparent Vaccine Supply Management through Blockchain." International Research Journal on Advanced Engineering Hub (IRJAEH) 3, no. 05 (2025): 2441–44. https://doi.org/10.47392/irjaeh.2025.0362.

Testo completo
Abstract (sommario):
With global health crises like COVID-19, making sure vaccines are safe and traceable has become very important. Blockchain technology offers a strong solution to improve vaccine supply management and stop the spread of fake vaccines. It does this by creating secure, unchangeable, and decentralized records. This paper explores how blockchain can track every step of a vaccine’s journey from production to delivery. Technologies like Ethereum, smart contracts, cloud storage, and QR codes are used to make the process more efficient and transparent. Smart contracts help ensure that only approved vac
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Fanelli, Angela, Luca Mantegazza, Saskia Hendrickx, and Ilaria Capua. "Thermostable Vaccines in Veterinary Medicine: State of the Art and Opportunities to Be Seized." Vaccines 10, no. 2 (2022): 245. http://dx.doi.org/10.3390/vaccines10020245.

Testo completo
Abstract (sommario):
The COVID-19 pandemic has highlighted the weakness of the vaccine supply chain, and the lack of thermostable formulations is one of its major limitations. This study presents evidence from peer-reviewed literature on the development of thermostable vaccines for veterinary use. A systematic review and meta-analysis were performed to evaluate the immunogenicity and/or the efficacy/effectiveness of thermostable vaccines against infectious diseases. The selected studies (n = 78) assessed the vaccine’s heat stability under different temperature conditions and over different periods. Only one study
Gli stili APA, Harvard, Vancouver, ISO e altri
20

Perrone, Pier Mario, Simona Scarioni, Elisa Astorri, et al. "Vaccination Open Day: A Cross-Sectional Study on the 2023 Experience in Lombardy Region, Italy." International Journal of Environmental Research and Public Health 21, no. 6 (2024): 685. http://dx.doi.org/10.3390/ijerph21060685.

Testo completo
Abstract (sommario):
Background: Vaccination is a highly effective tool for controlling infectious diseases, particularly in populations at high risk of contagion due to clinical conditions or occupational exposure, such as healthcare workers. The purpose of this study is to present the open day event that marked the beginning of the influenza and anti-COVID-19 vaccination campaign in the Lombardy region and to describe the experience of an Istituto di Ricovero e Cura a Carattere Scientifico in Milan. Methods: During the vaccination open day, eligible individuals received free vaccinations for influenza, COVID-19,
Gli stili APA, Harvard, Vancouver, ISO e altri
21

Devi, W. Roseybala, Supriya S. Kammar, S. Logesh, Gareth L. Dsouza, Thotegowdanapalya C. Mohan, and Charukesi Rajulu. "Nucleic Acid Vaccines." Journal of Preventive, Diagnostic and Treatment Strategies in Medicine 1, no. 4 (2022): 217–33. http://dx.doi.org/10.4103/jpdtsm.jpdtsm_85_22.

Testo completo
Abstract (sommario):
DNA vaccines, a type of nucleic acid vaccine, have emerged as one of the recent developments in immunology and recombinant DNA technology, offering great potential in terms of ease of manufacture, maintenance, and safety compared to conventional vaccines. Since their discovery, DNA vaccines have evolved immensely, resulting in the employment of new techniques such as gene guns, in vivo electroporation, and nanoparticle-based carriers to enhance the delivery of vaccines into the cells. Starting from the failures of the first-generation DNA vaccines to the near-success second-generation vaccines
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Tan, Swan, Andres Hazaet Gutiérrez, Phillip Charles Gauger, et al. "Quantifying the Persistence of Vaccine-Related T Cell Epitopes in Circulating Swine Influenza A Strains from 2013–2017." Vaccines 9, no. 5 (2021): 468. http://dx.doi.org/10.3390/vaccines9050468.

Testo completo
Abstract (sommario):
When swine flu vaccines and circulating influenza A virus (IAV) strains are poorly matched, vaccine-induced antibodies may not protect from infection. Highly conserved T cell epitopes may, however, have a disease-mitigating effect. The degree of T cell epitope conservation among circulating strains and vaccine strains can vary, which may also explain differences in vaccine efficacy. Here, we evaluate a previously developed conserved T cell epitope-based vaccine and determine the persistence of T cell epitope conservation over time. We used a pair-wise homology score to define the conservation
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Hasija, Manvi, Jian X. Ma, Bing Li, Nausheen Rahman, Kirsten A. Strahlendorf, and Salvador F. Ausar. "Determination of Deamidation in Adjuvanted Vaccine Antigens through Isoaspartic Acid Quantification." Vaccines 12, no. 7 (2024): 733. http://dx.doi.org/10.3390/vaccines12070733.

Testo completo
Abstract (sommario):
Deamidation is a post-translational chemical modification that occurs within proteins and can be influenced by many factors, including temperature and pH. In vaccines, deamidation is considered undesirable as it may lead to changes in structure, function, stability, and immunogenicity. Detecting deamidation in vaccines, especially adjuvanted vaccines, can be challenging due to the lack of simple quantitative techniques. In this study, the quantification of isoaspartic acid (isoAsp) was used to assess deamidation in model antigens in the presence and absence of common vaccine adjuvants. This st
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Steinhoff, Mark C., George F. Reed, Michael D. Decker, et al. "A Randomized Comparison of Reactogenicity and Immunogenicity of Two Whole-Cell Pertussis Vaccines." Pediatrics 96, no. 3 (1995): 567–70. http://dx.doi.org/10.1542/peds.96.3.567.

Testo completo
Abstract (sommario):
Objective. To compare prospectively the reactogenicity and immunogenicity of two licensed whole-cell pertussis vaccines. Methods. We conducted a prospective, randomized, double-blinded assessment of two licensed whole-cell pertussis vaccines with diphtheria and tetanus toxoids that were included in a multicenter trial evaluating 13 acellular pertussis vaccines. Infants were immunized at 2, 4, and 6 months of age with a single lot of Lederle (309 infants) or Massachusetts Public Health Biologic Laboratories (MPHBL; 94 infants) vaccine. Results. The group receiving the Lederle vaccine demonstrat
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Mikhael, Ehab Mudher, Samer Imad Mohammed, and Khalid Abdulhussein Abdulameer. "Knowledge, Attitudes, and Perceptions about COVID-19 and its Vaccine among Patients with Rheumatoid Arthritis: A Qualitative Study." Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 6, no. 1 (2023): 14–19. http://dx.doi.org/10.54133/ajms.v6i1.403.

Testo completo
Abstract (sommario):
Background: Despite the importance of vaccines in preventing COVID-19, the willingness to receive COVID-19 vaccines is lower among RA patients than in the general population. Objective: To determine the extent of COVID-19 knowledge among RA patients and their attitudes and perceptions of COVID-19 vaccines. Methods: A qualitative study with a phenomenology approach was performed through face-to-face, individual-based, semi-structured interviews in the Baghdad Teaching Hospital, Baghdad, Iraq, rheumatology unit. A convenient sample of RA patients using disease-modifying anti-rheumatic drugs was
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Fleming, Thomas R., Martha Nason, Philip R. Krause, Ira M. Longini, and Ana-Maria Henao-Restrepo. "COVID-19 vaccine trials: The potential for “hybrid” analyses." Clinical Trials 18, no. 4 (2021): 391–97. http://dx.doi.org/10.1177/17407745211018613.

Testo completo
Abstract (sommario):
Background: Although several COVID-19 vaccines have been found to be effective in rigorous evaluation and have emerging availability in parts of the world, their supply will be inadequate to meet international needs for a considerable period of time. There also will be continued interest in vaccines that are more effective or have improved scalability to facilitate mass vaccination campaigns. Ongoing clinical testing of new vaccines also will be needed as variant strains continue to emerge that may elude some aspects of immunity induced by current vaccines. Randomized clinical trials meaningfu
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Strugnell, Dick. "Vaccines." Microbiology Australia 32, no. 3 (2011): 114. http://dx.doi.org/10.1071/ma11114.

Testo completo
Abstract (sommario):
Vaccines are, without question, one of the most cost-effective and socially acceptable health interventions yet developed and expanding vaccine coverage is a key enabling strategy for achieving the Millennium Development Goals. As a challenge, the expanded and effective use of existing vaccines sits alongside the development of new and improved vaccines for preventing diseases which continue to have a major impact on humanity ? diseases such as HIV/AIDS, tuberculosis and malaria. Because vaccine development is stringently controlled by regulatory authorities and the costs of producing new vacc
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Kulindwa, Yusuph John, and Harun John Lothy. "Prior and Post-Covid-19 vaccination in Developing Countries: Does Household Willingness to Pay for Vaccine Matter?" Business and Economic Research 15, no. 1 (2025): 173. https://doi.org/10.5296/ber.v15i1.22420.

Testo completo
Abstract (sommario):
The emergence of the COVID-19 pandemic negatively impacted human life and made it necessary to examine the WTP for vaccines against the pandemic. Studying factors affecting the WTP for the COVID-19 vaccine before and after vaccination is crucial to understand the household WTP in these two situations. Following the panic from the pandemic, we anticipate different views and responses before and after the vaccine arrives in the country. We interviewed (461 and 396) respondents before and after the vaccine arrived in the country, respectively. The study aimed to uncover the driving factors of hou
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Felgendreff, Lisa, Felix G. Rebitschek, Mattis Geiger, Parichehr Shamsrizi, Mirjam A. Jenny, and Cornelia Betsch. "Explaining the Mechanism Behind mRNA Vaccines Influences Perceived Vaccine Effectiveness but not Vaccination Intentions." European Journal of Health Communication 5, no. 1 (2024): 21–45. http://dx.doi.org/10.47368/ejhc.2024.102.

Testo completo
Abstract (sommario):
Vaccine effectiveness and safety concerns can prevent people from receiving their first Covid-19 vaccines or boosters. Understanding the vaccine mechanism may lead people to perceive vaccine effectiveness appropriately. This study tested whether helping people understand the vaccine’s mechanism could improve their perceived vaccine safety and effectiveness. In a preregistered study, N = 1,548 unvaccinated or non-boosted participants were randomly presented with one of three communication formats: a fact box (a benefit-risk profile in tabular format; control condition), an expository text (i.e.
Gli stili APA, Harvard, Vancouver, ISO e altri
30

Tang, Jinyi, Cong Zeng, Thomas M. Cox, et al. "Respiratory humoral and cellular immune responses following COVID-19 mRNA vaccination." Journal of Immunology 208, no. 1_Supplement (2022): 65.22. http://dx.doi.org/10.4049/jimmunol.208.supp.65.22.

Testo completo
Abstract (sommario):
Abstract Vaccination is the key for controlling COVID-19 pandemic. SARS-CoV-2 mRNA vaccines have been demonstrated to induce robust and persistent humoral and cellular immunity in the circulation, but the vaccine-induced immune responses in the respiratory tract remain largely elusive. Here, we examined SARS-CoV-2 S-specific antibody, B and T cell immune responses in the bronchoalveolar lavage (BAL) fluid and blood from unvaccinated, COVID-19 vaccinees or COVID-19 convalescents that recovered from prior moderate to severe SARS-CoV-2 infection. We found that mRNA vaccination induced significant
Gli stili APA, Harvard, Vancouver, ISO e altri
31

Salat, Jiri, Kamil Mikulasek, Osmany Larralde, et al. "Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and May Elicit NS1-Specific Antibody Responses in Vaccinated Individuals." Vaccines 8, no. 1 (2020): 81. http://dx.doi.org/10.3390/vaccines8010081.

Testo completo
Abstract (sommario):
Vaccination against tick-borne encephalitis (TBE) is based on the use of formalin-inactivated, culture-derived whole-virus vaccines. Immune response following vaccination is primarily directed to the viral envelope (E) protein, the major viral surface antigen. In Europe, two TBE vaccines are available in adult and pediatric formulations, namely FSME-IMMUN® (Pfizer) and Encepur® (GlaxoSmithKline). Herein, we analyzed the content of these vaccines using mass spectrometry (MS). The MS analysis revealed that the Encepur vaccine contains not only proteins of the whole virus particle, but also viral
Gli stili APA, Harvard, Vancouver, ISO e altri
32

Wang, Wei, Dequan Pan, Tong Cheng, and Hua Zhu. "Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives." Viruses 14, no. 5 (2022): 848. http://dx.doi.org/10.3390/v14050848.

Testo completo
Abstract (sommario):
Primary varicella-zoster virus (VZV) infection causes varicella, which remains a prominent public health concern in children. Current varicella vaccines adopt the live-attenuated Oka strain, vOka, which retains the ability to infect neurons, establish latency and reactivate, leading to vaccine-associated zoster in some vaccinees. Therefore, it is necessary to develop a safer next-generation varicella vaccine to help reduce vaccine hesitancy. This paper reviews the discovery and identification of the skin- and neuro-tropic factor, the open reading frame 7 (ORF7) of VZV, as well as the developme
Gli stili APA, Harvard, Vancouver, ISO e altri
33

Crum, Tommie, Kirsten Mooney, and Birendra R. Tiwari. "Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases." F1000Research 10 (December 7, 2021): 652. http://dx.doi.org/10.12688/f1000research.51160.2.

Testo completo
Abstract (sommario):
Background: Vaccines have had a great impact on disease prevention and reducing mortality. Very rarely, vaccines also can result in serious adverse effects. In consideration of this fact, vaccine injury compensation programs have been implemented in many countries to compensate a vaccinee for associated adverse effects. The existing vaccine injury compensation system addresses routine immunization schemes. However, there are rising concerns about the compensation for adverse effects caused by new vaccines such as those developed for coronavirus disease 2019 (COVID-19). This review focuses on v
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Crum, Tommie, Kirsten Mooney, and Birendra R. Tiwari. "Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases." F1000Research 10 (July 26, 2021): 652. http://dx.doi.org/10.12688/f1000research.51160.1.

Testo completo
Abstract (sommario):
Background: Vaccines have had a great impact on disease prevention and mortality reduction. Very rarely, vaccines also can result in serious adverse effects. In consideration of this fact, vaccine injury compensation programs have been implemented in many countries to compensate a vaccinee for associated adverse effects. The existing vaccine injury compensation system addresses routine immunization schemes. However, there are rising concerns about the compensation for adverse effects caused by new vaccines such as those developed for coronavirus disease 2019 (COVID-19). The objective of this a
Gli stili APA, Harvard, Vancouver, ISO e altri
35

Lin, Jihan. "New Possibilities for Cancer Immunotherapy Discovered Through Cancer Vaccines." Highlights in Science, Engineering and Technology 74 (December 29, 2023): 1680–87. http://dx.doi.org/10.54097/rxtkht22.

Testo completo
Abstract (sommario):
Cancer vaccine, a type of cancer immunotherapy, works by enhancing the identification and eradicating antigens, preventing cancer recurrence and stopping the growth or spread of tumors function. Because cancer vaccines are highly specific and therapeutically effective in preventing and treating cancer, it is gradually becoming the mainstay of cancer immunotherapy. First, some malignancies have relatively poor immunotherapy response rates, thus it's important to talk about ways to boost reactive T cell activity. In addition, how to combine cancer vaccines with other immunotherapies will be a ch
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Souan, Lina, Hikmat Abdel-Razeq, Muna Al Zughbieh, Sara Al Badr, and Maher A. Sughayer. "Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients." Viruses 15, no. 7 (2023): 1439. http://dx.doi.org/10.3390/v15071439.

Testo completo
Abstract (sommario):
Objective: The kinetics of immune responses to various SARS-CoV-2 vaccines in cancer patients were investigated. Methods: In total, 57 cancer patients who received BNT162b2-RNA or BBIBP-CorV vaccines were enrolled. Cellular and humoral immunity were assessed at three-time points, before the first vaccine dose and 14–21 days after the first and second doses. Chemiluminescent microparticle immunoassay was used to evaluate SARS-CoV-2 anti-spike IgG response, and QuantiFERON® SARS-CoV-2 kit assessed T-cell response. Results: Data showed that cancer patients’ CD4+ and CD8+ T cell-median IFN-γ secre
Gli stili APA, Harvard, Vancouver, ISO e altri
37

Giannecchini, Simone, Patrizia Isola, Olimpia Sichi, et al. "AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts." Journal of Virology 76, no. 14 (2002): 6882–92. http://dx.doi.org/10.1128/jvi.76.14.6882-6892.2002.

Testo completo
Abstract (sommario):
ABSTRACT Immunogenicity and protective activity of four cell-based feline immunodeficiency virus (FIV) vaccines prepared with autologous lymphoblasts were investigated. One vaccine was composed of FIV-infected cells that were paraformaldehyde fixed at the peak of viral expression. The other vaccines were attempts to maximize the expression of protective epitopes that might become exposed as a result of virion binding to cells and essentially consisted of cells mildly fixed after saturation of their surface with adsorbed, internally inactivated FIV particles. The levels of FIV-specific lymphopr
Gli stili APA, Harvard, Vancouver, ISO e altri
38

Gokdemir, Ozden, Selda Yorok, Bennur Koca, and Ayla Acikgoz. "Vaccine hesitancy among university students of healthcare." Medicine Science | International Medical Journal 11, no. 4 (2022): 1581. http://dx.doi.org/10.5455/medscience.2022.08.179.

Testo completo
Abstract (sommario):
The World Health Organization defines vaccine hesitancy as "the refusal or delay in accepting vaccines despite the availability of immunization services." When a person rejects all vaccines, it is referred to as vaccine rejection. Vaccine hesitancy stems from a lack of trust in the vaccine and apprehension about side effects, as well as a lack of knowledge about vaccines and sociocultural factors. The research aims to determine the COVID-19 vaccine indecision and attitudes of students studying in the field of health. This study is a cross-sectional research project. Vaccine rejection is among
Gli stili APA, Harvard, Vancouver, ISO e altri
39

Khattak, Saadullah, Muhammad Idrees, Hafiza Iqra Iqbal, et al. "Assessment of Attitudes and Intentions towards COVID-19 Vaccines and Associated Factors among General Populations of Pakistan: A Cross-Sectional Study." Vaccines 10, no. 10 (2022): 1583. http://dx.doi.org/10.3390/vaccines10101583.

Testo completo
Abstract (sommario):
Objective: The goal of public health in combatting COVID-19 is to increase herd immunity. However, vaccine reluctance makes attaining herd immunity a worldwide challenge. This investigation aimed to identify negative and positive attitudes and intentions about COVID-19 vaccinations. Methods: A cross-sectional online survey was conducted once free COVID-19 vaccines became available in Pakistan in 2021. 4392 Pakistanis aged 18 and older were surveyed from seven administrative units between 1 July and 30 August 2021. Online structured questionnaires were utilized to collect data using a simple sa
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Liu, Chuyao, Aiyun Lu, and Xiaoyu Wu. "COVID-19 Vaccine Comparison: How to Choose the Best Suiting Vaccine for Different Needs." E3S Web of Conferences 292 (2021): 03080. http://dx.doi.org/10.1051/e3sconf/202129203080.

Testo completo
Abstract (sommario):
Varied measurements have been developed to solve the COVID-19 pandemic, and one of the best ways is vaccines. This paper aims to compare different kinds of vaccines and help people or countries to choose the best suitable vaccine needs based on their different needs. It provides a broader and more detailed analysis of variant vaccines on different levels. In the sequence of technology maturity, inactivated vaccines including CoronaVac, BBIBP-CorV vaccine, and WIBP-CorV vaccine, viral-based vector vaccines including AstraZeneca COVID-19 vaccine and Johnson & Johnson’s COVID-19 vaccine, and
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Knight-Jones, T. J. D., K. Edmond, S. Gubbins, and D. J. Paton. "Veterinary and human vaccine evaluation methods." Proceedings of the Royal Society B: Biological Sciences 281, no. 1784 (2014): 20132839. http://dx.doi.org/10.1098/rspb.2013.2839.

Testo completo
Abstract (sommario):
Despite the universal importance of vaccines, approaches to human and veterinary vaccine evaluation differ markedly. For human vaccines, vaccine efficacy is the proportion of vaccinated individuals protected by the vaccine against a defined outcome under ideal conditions, whereas for veterinary vaccines the term is used for a range of measures of vaccine protection. The evaluation of vaccine effectiveness , vaccine protection assessed under routine programme conditions, is largely limited to human vaccines. Challenge studies under controlled conditions and sero-conversion studies are widely us
Gli stili APA, Harvard, Vancouver, ISO e altri
42

Mahesh, Kumar Yadav1 Ankit Kumar Srivastava2 Madhu Vishwakarma2 Juveriya Javed2 Manu Kumar2 Nitu Singh2 Sudhanshu Shekhar2 Gagan Gaykwad2 Faizan Ansari2 Sonu Kumar2 Anchal Kumari2 Deepika Kumari2 Shyam Narayan2 Ramesh Kumar2 Naba Gorai2 Ankita Singh3 Arnab Roy*4 Meghna Singh5. "Comparative Analysis of Immunological Responses and Molecular Mechanisms In SARS-Cov-2 Vaccine Development: Insights from Covishield And Covaxin." International Journal of Scientific Research and Technology 2, no. 5 (2025): 556–83. https://doi.org/10.5281/zenodo.15518160.

Testo completo
Abstract (sommario):
The unprecedented global COVID-19 pandemic catalyzed an extraordinary scientific endeavor in vaccine development, with India emerging as a pivotal contributor through two innovative vaccine platforms: Covishield and Covaxin. These vaccines represent sophisticated molecular engineering strategies addressing the urgent need for effective SARS-CoV-2 intervention mechanisms. Covishield, utilizing a chimpanzee adenoviral vector (ChAdOx1), exemplifies advanced viral vector technology, strategically delivering the spike protein genetic sequence to induce robust immunological responses. The vaccine's
Gli stili APA, Harvard, Vancouver, ISO e altri
43

Zhu, Hongwei. "Exploring the value of mRNA vaccines." Theoretical and Natural Science 16, no. 1 (2023): 244–49. http://dx.doi.org/10.54254/2753-8818/16/20240598.

Testo completo
Abstract (sommario):
Vaccine development has now been widely used in various medical fields, such as disease prevention, cancer treatment, etc. Therefore, vaccine development has been a hot topic in the medical field in recent years. According to different production methods, vaccines can be divided into three categories: whole-microbial vaccines, subunit vaccines, and genetic vaccines. This article focuses on the design of vaccines using only genetic material, known as genetic vaccines. This type of vaccine is a vaccine that uses specific genetic material to transcribe and translate specific proteins to produce s
Gli stili APA, Harvard, Vancouver, ISO e altri
44

Camacho, Luiz Antonio Bastos, Marcos da Silva Freire, Maria da Luz Fernandes Leal, et al. "Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial." Revista de Saúde Pública 38, no. 5 (2004): 671–78. http://dx.doi.org/10.1590/s0034-89102004000500009.

Testo completo
Abstract (sommario):
OBJECTIVE: To compare the immunogenicity of three yellow fever vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots). METHODS: An equivalence trial was carried out involving 1,087 adults in Rio de Janeiro. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered following standardized procedures adapted to allow blocked randomized allocation of participants to coded vaccine types (double-blind). Neutralizing yellow fever antibody titters were compared in pre- and post-immunization serum samples. Equivalence was defined as a difference of no mo
Gli stili APA, Harvard, Vancouver, ISO e altri
45

Whelan, Allison M. "Lowering the Age of Consent: Pushing Back against the Anti-Vaccine Movement." Journal of Law, Medicine & Ethics 44, no. 3 (2016): 462–73. http://dx.doi.org/10.1177/1073110516667942.

Testo completo
Abstract (sommario):
This article examines the rise of the anti-vaccination movement, the proliferation of laws allowing parental exemptions to mandatory school vaccines, and the impact of the movement on immunization rates for all vaccines. It uses the ongoing debate about the Human Papillomavirus (HPV) vaccine as an example to highlight the ripple effect and consequences of the anti-vaccine movement despite robust evidence of the vaccine's safety and efficacy. The article scrutinizes how state legislatures ironically promote vaccination while simultaneously deferring to the opposition by promulgating broad opt-o
Gli stili APA, Harvard, Vancouver, ISO e altri
46

Dr.U.Srineetha, Nagendra Kumar Dr.D.Veera, and Rao Dr.C.Narasimha. "Fish Health Maintenance in Aquaculture and Prevention and Control of Infectious Disease of Fish." International Journal of Advance and Applied Research 4, no. 8 (2023): 1–5. https://doi.org/10.5281/zenodo.7800622.

Testo completo
Abstract (sommario):
Aquaculture is rapidly growing part of agriculture worldwide. The relationship between microorganisms and fish can be either mutualistic or pathogenic. In the majority of cases, fish diseases caused by pathogenic bacteria are among the most prevalent epidemics in the aquaculture industry.  It makes up around 53 percent of total fish production globally. This increased growth of production is achieved despite facing many challenges in the aquaculture environment. Among production limiting challenges, the infectious disease takes the lion share by causing multibillion-dollar loss annually.
Gli stili APA, Harvard, Vancouver, ISO e altri
47

Kebabçıoğlu, Canan, Osman Erganiş, and Adam Tawor. "Next Generation Vaccines." Dicle Üniversitesi Veteriner Fakültesi Dergisi 17, no. 2 (2024): 204–10. https://doi.org/10.47027/duvetfd.1474558.

Testo completo
Abstract (sommario):
For centuries, mankind has been aware that prevention is more valuable than cure and has sought appropriate ways to do so. The adventure of vaccination, known as the most effective protection method, began with studies against smallpox. It continued when Edward Jenner administered the vaccinia virus to a child in 1796, which he received from a woman infected by a cow. Louis Pasteur observed that the virus administered in 1798 eliminated the smallpox virus after a few months, so the smallpox vaccine was first discovered and applied. The concept of inactivated vaccines emerged during the collabo
Gli stili APA, Harvard, Vancouver, ISO e altri
48

Chang, Jane Y., Curt Balch, and Hyung Suk Oh. "Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond." Viruses 16, no. 9 (2024): 1476. http://dx.doi.org/10.3390/v16091476.

Testo completo
Abstract (sommario):
Herpes simplex virus (HSV) has coevolved with Homo sapiens for over 100,000 years, maintaining a tenacious presence by establishing lifelong, incurable infections in over half the human population. As of 2024, an effective prophylactic or therapeutic vaccine for HSV remains elusive. In this review, we independently screened PubMed, EMBASE, Medline, and Google Scholar for clinically relevant articles on HSV vaccines. We identified 12 vaccines from our literature review and found promising candidates across various classes, including subunit vaccines, live vaccines, DNA vaccines, and mRNA vaccin
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Turlewicz-Podbielska, Hanna, Anna Kuriga, Rafał Niemyjski, Grzegorz Tarasiuk, and Małgorzata Pomorska-Mól. "African Swine Fever Virus as a Difficult Opponent in the Fight for a Vaccine—Current Data." Viruses 13, no. 7 (2021): 1212. http://dx.doi.org/10.3390/v13071212.

Testo completo
Abstract (sommario):
Prevention and control of African swine fever virus (ASFV) in Europe, Asia, and Africa seem to be extremely difficult in view of the ease with which it spreads, its high resistance to environmental conditions, and the many obstacles related to the introduction of effective specific immunoprophylaxis. Biological properties of ASFV indicate that the African swine fever (ASF) pandemic will continue to develop and that only the implementation of an effective and safe vaccine will ensure a reduction in the spread of ASFV. At present, vaccines against ASF are not available. The latest approaches to
Gli stili APA, Harvard, Vancouver, ISO e altri
50

Lu, Zhichen. "How successful are some existing vaccinations in preventing COVID?" Transactions on Materials, Biotechnology and Life Sciences 1 (November 13, 2023): 106–13. http://dx.doi.org/10.62051/2sf0rs31.

Testo completo
Abstract (sommario):
The COVID-19 pandemic has placed immense pressure on the global healthcare sector. The rapid development of vaccines has significantly alleviated the rampant spread of the COVID-19 virus. This research paper aims to determine the success rates of various types of vaccines in preventing COVID. It will first list the brand of the vaccine, then identify the type of vaccine, and describe how the vaccine functions in providing the body immunity from the coronavirus, and finally it will compare the vaccines’ success rates in preventing the patient from being infected with COVID. Coronavirus vaccine
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!